Does PEMIGATINIB Cause Disease progression? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Disease progression have been filed in association with PEMIGATINIB (PEMAZYRE). This represents 14.5% of all adverse event reports for PEMIGATINIB.
103
Reports of Disease progression with PEMIGATINIB
14.5%
of all PEMIGATINIB reports
38
Deaths
13
Hospitalizations
How Dangerous Is Disease progression From PEMIGATINIB?
Of the 103 reports, 38 (36.9%) resulted in death, 13 (12.6%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for PEMIGATINIB.
What Other Side Effects Does PEMIGATINIB Cause?
Off label use (114)
Death (76)
Fatigue (72)
Alopecia (53)
Hyperphosphataemia (46)
Cholangiocarcinoma (44)
Diarrhoea (42)
Constipation (37)
Drug ineffective (37)
Hospitalisation (35)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which PEMIGATINIB Alternatives Have Lower Disease progression Risk?
PEMIGATINIB vs PENICILLAMINE
PEMIGATINIB vs PENICILLIN
PEMIGATINIB vs PENICILLIN G
PEMIGATINIB vs PENICILLIN G BENZATHINE
PEMIGATINIB vs PENICILLIN G PROCAINE